DR info

臨床試験数 : 16 / 薬物数 : 26 - (DrugBank : 5) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 14

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Autologous umbilical cord blood
   The University of Texas Health Science Center, Houston
      2018   Phase 1   NCT03526588   United States;
Bronchodilator Response
   The Hospital for Sick Children
      2012   -   NCT02453750   Canada;
Hypersaline
   The Hospital for Sick Children
      2012   -   NCT02453750   Canada;
INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden;
INALOSSIN 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden;
INOmax 800ppm mol/mol inhalatiegas
   Erasmus MC
      2019   Phase 3   EUCTR2017-000421-13-BE   Austria;Belgium;Netherlands;
      2018   Phase 4   EUCTR2017-000421-13-AT   Austria;Netherlands;
      2017   Phase 3   EUCTR2017-000421-13-NL   Austria;Belgium;Netherlands;Norway;Sweden;
      -   Phase 3   EUCTR2017-000421-13-SE   Austria;Belgium;Netherlands;Norway;Sweden;
      -   Phase 3   EUCTR2017-000421-13-NO   Austria;Belgium;Netherlands;Norway;
Inhaled Nitric Oxide (iNO) use
   The University of Texas Health Science Center, Houston
      2023   Phase 4   NCT05213676   United States;
Losec
   ErasmusMC
      2013   -   EUCTR2013-002026-22-NL   Netherlands;
Milrinone
   NICHD Neonatal Research Network
      2017   Phase 2   NCT02951130   United States;
Neophyr 1000ppm mol/mol
   Erasmus MC
      2019   Phase 3   EUCTR2017-000421-13-BE   Austria;Belgium;Netherlands;
      -   Phase 3   EUCTR2017-000421-13-NO   Austria;Belgium;Netherlands;Norway;
OSSIDO DI AZOTO
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden;
Omeprazol
   ErasmusMC
      2013   -   EUCTR2013-002026-22-NL   Netherlands;
Omeprazole rectally
   Rijnstate Hospital
      2005   Phase 3   NCT00226044   Netherlands;
Oxygen
   Medical University of Graz
      2018   -   NCT03787160   Austria;
Probiotic treatment
   Medical University of Graz
      2018   -   NCT03787160   Austria;
REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden;
Repair of CDH w/Alloderm
   Children's Mercy Hospital Kansas City
      2005   Phase 3   NCT00257946   United States;
Repair of CDH w/SIS Gold
   Children's Mercy Hospital Kansas City
      2005   Phase 3   NCT00257946   United States;
Revatio 0.8mg/ml solution for injection
   Erasmus MC
      2019   Phase 3   EUCTR2017-000421-13-BE   Austria;Belgium;Netherlands;
      2018   Phase 4   EUCTR2017-000421-13-AT   Austria;Netherlands;
      2017   Phase 3   EUCTR2017-000421-13-NL   Austria;Belgium;Netherlands;Norway;Sweden;
      -   Phase 3   EUCTR2017-000421-13-SE   Austria;Belgium;Netherlands;Norway;Sweden;
      -   Phase 3   EUCTR2017-000421-13-NO   Austria;Belgium;Netherlands;Norway;
Sildenafil
   ERASMUS MEDICAL CENTER
      2020   Phase 3   EUCTR2017-000421-13-IT   Austria;Belgium;Germany;Italy;Netherlands;Norway;Spain;Sweden;
   Erasmus MC
      2018   Phase 4   EUCTR2017-000421-13-AT   Austria;Netherlands;
   Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
      2020   Phase 0   ChiCTR2000037331   China;